Why is Mangalam Drugs falling/rising?

As of 16-Sep, Mangalam Drugs and Organics Ltd is experiencing a decline in its stock price, currently at 74.95, which reflects a decrease of 0.61 or 0.81%. The stock has underperformed its sector by 1.09% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has fallen by 3.25%, and it has shown significant declines over longer periods, with a year-to-date drop of 35.36% and a one-year decline of 44.91%. Notably, there has been a rise in investor participation, with delivery volume increasing by 88.88% compared to the 5-day average, indicating some interest despite the overall negative performance. There are no specific positive or negative factors provided that could further explain the stock's recent movement.
In the broader market context, Mangalam Drugs' performance has been notably weaker compared to the benchmark Sensex, which has gained 1.58% over the past week. This stark contrast highlights the stock's struggles, as it has not only underperformed in the short term but also over longer periods, with a three-year decline of 51.05% compared to the Sensex's increase of 40.01%. The overall market sentiment appears to favor other sectors, contributing to the continued downward pressure on Mangalam Drugs' stock price.